Palestinian Children in the Hemato-Oncology Ward of an Israeli Hospital

Por Nehari, Miri, Bielorai, Bella, Toren, Amos
Publicado em 2008

The Gut–Brain Axis, Paving the Way to Brain Cancer

Por Mehrian-Shai, Ruty, Reichardt, Juergen K.V., Harris, Curtis C., Toren, Amos
Publicado no Trends Cancer (2019)

Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients

Por Yalon, Michal, Toren, Amos, Jabarin, Dina, Fadida, Edna, Constantini, Shlomi, Mehrian-Shai, Ruty
Publicado no Front Oncol (2019)

MEDU-30. IDENTIFYING DISTINCTIVE lincRNAs IN THE DIFFERENT MEDULLOBLASTOMA SUBGROUPS

Por Freedman, Shany, Yalon, Michal, Eyal, Eran, Kol, Nitzan, Remke, Marc, Toren, Amos, Mehrian-Shai, Ruty
Publicado no Neuro Oncol (2019)

Genetic Linkage of Autosomal-Dominant Alport Syndrome with Leukocyte Inclusions and Macrothrombocytopenia (Fechtner Syndrome) to Chromosome 22q11-13

Por Toren, Amos, Amariglio, Ninette, Rozenfeld-Granot, Galit, Simon, Amos J., Brok-Simoni, Frida, Pras, Elon, Rechavi, Gideon
Publicado em 1999

MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells

Por Versano, Ziv, Shany, Eitan, Freedman, Shany, Tuval-Kochen, Liron, Leitner, Moshe, Paglin, Shoshana, Toren, Amos, Yalon, Michal
Publicado no Oncotarget (2018)

Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells

Por Hershkovitz Rokah, Oshrat, Granot, Galit, Ovcharenko, Adelina, Modai, Shira, Pasmanik-Chor, Metsada, Toren, Amos, Shomron, Noam, Shpilberg, Ofer
Publicado em 2012

Novel age-dependent targets in vestibular schwannomas

Por Toren, Amos, Reichardt, Juergen K, Andalibi, Ali, Hsu, Nancy Ya-Hsuan, Doherty, Joni, Slattery, William, Mehrian-Shai, Ruty
Publicado em 2014

High metallothionein predicts poor survival in glioblastoma multiforme

Por Mehrian-Shai, Ruty, Yalon, Michal, Simon, Amos J., Eyal, Eran, Pismenyuk, Tatyana, Moshe, Itai, Constantini, Shlomi, Toren, Amos
Publicado no BMC Med Genomics (2015)

Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment

Por Tuval-Kochen, Liron, Paglin, Shoshana, Keshet, Gilmor, Lerenthal, Yaniv, Nakar, Charles, Golani, Tamar, Toren, Amos, Yahalom, Joachim, Pfeffer, Raphael, Lawrence, Yaacov
Publicado em 2013

CB-02 MiRNA EXPRESSION PROFILES OF GLIOMA STEM CELLS AND THEIR ASSOCIATION WITH THE MESENCHYMAL TRANSFORMATION OF THESE CELLS

Por Bier, Ariel, Finniss, Susan, Cazacu, Simona, Xiang, Cunli, Lee, Hae Kyung, Rand, Daniel, Yalon, Michal, Toren, Amos, Poisson, Laila, Brodie, Chaya
Publicado em 2014

Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis

Por Mehrian-Shai, Ruty, Yalon, Michal, Moshe, Itai, Barshack, Iris, Nass, Dvorah, Jacob, Jasmine, Dor, Chen, Reichardt, Juergen K. V., Constantini, Shlomi, Toren, Amos
Publicado no BMC Genomics (2016)

Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient

Por Amariglio, Ninette, Hirshberg, Abraham, Scheithauer, Bernd W, Cohen, Yoram, Loewenthal, Ron, Trakhtenbrot, Luba, Paz, Nurit, Koren-Michowitz, Maya, Waldman, Dalia, Leider-Trejo, Leonor, Toren, Amos, Constantini, Shlomi, Rechavi, Gideon
Publicado em 2009

Related to testes-specific, vespid and pathogenesis protein-1 is regulated by methylation in glioblastoma

Por JACOBY, ELAD, YALON, MICHAL, LEITNER, MOSHE, COHEN, ZVI R., COHEN, YEHUDIT, FISHER, TAMAR, EDER, SARIT, AMARIGLIO, NINETTE, RECHAVI, GIDEON, CAZACU, SIMONA, XIANG, CUNLI, MIKKELSEN, TOM, BRODIE, CHAYA, TOREN, AMOS
Publicado em 2014

MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor

Por Lee, Hae Kyung, Bier, Ariel, Cazacu, Simona, Finniss, Susan, Xiang, Cunli, Twito, Hodaya, Poisson, Laila M., Mikkelsen, Tom, Slavin, Shimon, Jacoby, Elad, Yalon, Michal, Toren, Amos, Rempel, Sandra A., Brodie, Chaya
Publicado em 2013

Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)

Por Resnick, Igor B, Barkats, Claudine, Shapira, Michael Y, Stepensky, Polina, Bloom, Allan I, Shimoni, Avichai, Mankuta, David, Varda-Bloom, Nira, Rheingold, Lyudmila, Yeshurun, Moshe, Bielorai, Bella, Toren, Amos, Zuckerman, Tsila, Nagler, Arnon, Or, Reuven
Publicado em 2013

MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1

Por Bier, Ariel, Giladi, Nis, Kronfeld, Noam, Lee, Hae Kyung, Cazacu, Simona, Finniss, Susan, Xiang, Cunli, Poisson, Laila, deCarvalho, Ana C., Slavin, Shimon, Jacoby, Elad, Yalon, Michal, Toren, Amos, Mikkelsen, Tom, Brodie, Chaya
Publicado em 2013

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

Por Itzhaki, Orit, Jacoby, Elad, Nissani, Abraham, Levi, Michal, Nagler, Arnon, Kubi, Adva, Brezinger, Karin, Brayer, Hadar, Zeltzer, Li-at, Rozenbaum, Meir, Vernitsky, Helly, Markel, Gal, Toren, Amos, Avigdor, Abraham, Schachter, Jacob, Besser, Michal J
Publicado no J Immunother Cancer (2020)

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems

Por Toren, Amos, Pismenyuk, Tatyana, Yalon, Michal, Freedman, Shani, Simon, Amos J., Fisher, Tamar, Moshe, Itai, Reichardt, Juergen K.V., Constantini, Shlomi, Mardor, Yael, Last, David, Guez, David, Daniels, Dianne, Assoulin, Moria, Mehrian-Shai, Ruty
Publicado no Oncotarget (2016)

NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target

Por Shukrun, Rachel, Golan, Hana, Caspi, Revital, Pode-Shakked, Naomi, Pleniceanu, Oren, Vax, Einav, Bar-Lev, Dekel D., Pri-Chen, Sara, Jacob-Hirsch, Jasmine, Schiby, Ginette, Harari-Steinberg, Orit, Mark-Danieli, Michal, Dekel, Benjamin, Toren, Amos
Publicado no Oncogenesis (2019)